Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only preexisting vessels. This new view of GET may drive others to look at novel agents for treatment.
|Number of pages||3|
|Journal||Journal of Drugs in Dermatology|
|State||Published - Mar 2017|